Some evidence suggests that CDK4/6 inhibition leads to an RB-dependent increase in reactive oxygen species (ROS) levels, resulting in the activation of autophagy and limitation of senescence in breast cancer cells.648. Here, CDK4 is linked to breast carcinoma.